Wedge Capital Management L L P Biogen Inc. Transaction History
Wedge Capital Management L L P
- $5.42 Billion
- Q4 2024
A detailed history of Wedge Capital Management L L P transactions in Biogen Inc. stock. As of the latest transaction made, Wedge Capital Management L L P holds 179,191 shares of BIIB stock, worth $25.5 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
179,191
Previous 152,661
17.38%
Holding current value
$25.5 Million
Previous $29.6 Million
7.4%
% of portfolio
0.51%
Previous 0.52%
Shares
25 transactions
Others Institutions Holding BIIB
# of Institutions
994Shares Held
131MCall Options Held
1.12MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.37 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.32 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.07 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.05 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$748 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...